In a 65‑year‑old man with well‑controlled hypertension on two antihypertensive agents, a remote gastrointestinal illness, low serum creatinine, prior mild hyponatremia, current lymphopenia, rash and easy bruising with a normal platelet count, what laboratory and clinical work‑up and initial management steps are recommended?

Immediate Work-Up and Management for Lymphopenia, Rash, and Easy Bruising in a Hypertensive Patient

This patient requires urgent evaluation for a potential hematologic or autoimmune disorder, with immediate complete blood count with differential, comprehensive metabolic panel, peripheral blood smear, and dermatologic assessment to rule out serious conditions such as lymphoproliferative disorders, drug-induced cytopenias, or systemic vasculitis.

Critical Initial Laboratory Assessment

The constellation of lymphopenia, rash, and easy bruising with normal platelets demands immediate investigation beyond routine hypertension monitoring:

Essential First-Line Tests

• Complete blood count with manual differential – Confirm absolute lymphocyte count, evaluate for atypical lymphocytes, assess all cell lines
• Comprehensive metabolic panel – Reassess current sodium and creatinine levels (prior mild hyponatremia at 133 mEq/L and low creatinine warrant repeat measurement) 1
• Peripheral blood smear – Evaluate lymphocyte morphology, rule out malignant cells or dysplasia
• Coagulation studies (PT/INR, aPTT) – Despite normal platelets, easy bruising requires assessment of clotting factors
• Liver function tests – Evaluate for hepatic dysfunction contributing to bruising

Secondary Diagnostic Studies

• Lactate dehydrogenase (LDH) and uric acid – Screen for lymphoproliferative disorders or tumor lysis
• Antinuclear antibody (ANA), complement levels (C3, C4) – Evaluate for autoimmune conditions causing lymphopenia and rash
• HIV, hepatitis panel – Infectious causes of lymphopenia
• Vitamin B12, folate, TSH – Nutritional and endocrine causes of cytopenias

Hypertension Medication Review and Electrolyte Management

Given the patient's well-controlled hypertension on dual therapy with prior mild hyponatremia (133 mEq/L), medication-related adverse effects must be evaluated:

Assess for Diuretic-Related Complications

The prior hyponatremia strongly suggests thiazide diuretic use, which can cause:

• Hyponatremia – Thiazide-type diuretics are the most common cause 1
• Hypokalemia – May contribute to muscle weakness or other symptoms
• Volume depletion – Could explain low creatinine (reduced muscle mass or volume status)

Immediate action: Obtain current basic metabolic panel to reassess sodium and potassium. If sodium remains <135 mEq/L and patient is on a thiazide diuretic, consider discontinuation or dose reduction 1. The 2025 AHA/ACC guidelines emphasize that severe electrolyte imbalances require immediate discontinuation of the causative medication 1.

Low Creatinine Interpretation

Low serum creatinine typically indicates:

• Reduced muscle mass (sarcopenia in elderly)
• Malnutrition (consider given history of GI illness)
• Liver disease
• Not a medication side effect requiring intervention

However, changes in creatinine can help distinguish volume status. If creatinine has increased from prior low baseline during hyponatremia, this suggests hypovolemic hyponatremia from diuretic overuse 2. If creatinine decreased or remained stable, this favors euvolemic hyponatremia (SIADH) 2.

Dermatologic Evaluation

The rash requires urgent characterization:

Key Clinical Features to Document

• Distribution and morphology – Petechial (suggests vasculitis or thrombocytopenia despite normal platelet count), maculopapular (drug reaction), purpuric (coagulopathy), or other patterns
• Timing relative to medication changes – Drug-induced hypersensitivity can cause rash, lymphopenia, and coagulopathy
• Associated symptoms – Fever, joint pain, or systemic symptoms suggest vasculitis or autoimmune disease

Specific Considerations

• Drug reaction with eosinophilia and systemic symptoms (DRESS) – Can present with rash, lymphopenia (or eosinophilia), and organ involvement; ACE inhibitors and ARBs are potential culprits
• Cutaneous vasculitis – Small vessel vasculitis can cause palpable purpura and easy bruising with normal platelets
• Dermatology referral – Consider skin biopsy if rash is purpuric, vasculitic, or persistent

Management Algorithm

Step 1: Immediate Safety Assessment (Within 24 Hours)

1. Repeat CBC with differential and CMP
2. Review all current medications for potential causative agents
3. Assess for signs of infection, bleeding, or systemic illness
4. If sodium <125 mEq/L or symptomatic hyponatremia: Consider hospital admission for hypertonic saline 3, 4

Step 2: Medication Adjustment (Within 1 Week)

1. If thiazide diuretic confirmed and sodium <135 mEq/L: Discontinue or reduce dose 1
2. Alternative antihypertensive: Switch to calcium channel blocker or increase dose of existing non-diuretic agent to maintain BP control 1, 5
3. Monitor electrolytes: Recheck BMP 2-4 weeks after any medication change 1

Step 3: Hematologic Follow-Up (Within 2 Weeks)

1. If lymphopenia confirmed (<1,000 cells/μL): Hematology referral
2. If peripheral smear shows abnormalities: Expedite hematology evaluation
3. If autoimmune markers positive: Rheumatology referral

Step 4: Ongoing Monitoring

• Electrolytes: Every 2-4 weeks until stable, then every 3-6 months 1
• CBC: Repeat in 4-6 weeks to assess lymphopenia trajectory
• Blood pressure: Home monitoring to ensure continued control after medication adjustments

Critical Pitfalls to Avoid

1. Do not attribute all findings to hypertension medications alone – The triad of lymphopenia, rash, and easy bruising suggests a systemic process requiring comprehensive evaluation beyond medication side effects

2. Do not overlook malignancy – Lymphopenia with constitutional symptoms or unexplained rash may represent lymphoproliferative disorder or solid tumor

3. Do not rapidly correct chronic hyponatremia – If sodium has been low for >48 hours, correction should not exceed 8-10 mEq/L in 24 hours to avoid osmotic demyelination 3, 4, 6

4. Do not continue thiazide diuretics in persistent hyponatremia – This is a clear indication for medication discontinuation per current guidelines 1

5. Do not assume normal platelets exclude bleeding disorders – Easy bruising with normal platelet count requires coagulation factor assessment and consideration of platelet function defects or vascular disorders